Global Pneumococcal Vaccine Polyvalent Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pneumococcal Vaccine Polyvalent Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pneumococcal Vaccine Polyvalent by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pneumococcal Vaccine Polyvalent by Country/Region, 2017, 2022 & 2028

2.2 Pneumococcal Vaccine Polyvalent Segment by Type

2.2.1 Prevnar 13

2.2.2 Pneumovax23

2.3 Pneumococcal Vaccine Polyvalent Sales by Type

2.3.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

2.3.2 Global Pneumococcal Vaccine Polyvalent Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pneumococcal Vaccine Polyvalent Sale Price by Type (2017-2022)

2.4 Pneumococcal Vaccine Polyvalent Segment by Application

2.4.1 18 Years and Younger

2.4.2 19 To 64 Years Old

2.4.3 65 Years and Older

2.5 Pneumococcal Vaccine Polyvalent Sales by Application

2.5.1 Global Pneumococcal Vaccine Polyvalent Sale Market Share by Application (2017-2022)

2.5.2 Global Pneumococcal Vaccine Polyvalent Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pneumococcal Vaccine Polyvalent Sale Price by Application (2017-2022)

3 Global Pneumococcal Vaccine Polyvalent by Company

3.1 Global Pneumococcal Vaccine Polyvalent Breakdown Data by Company

3.1.1 Global Pneumococcal Vaccine Polyvalent Annual Sales by Company (2020-2022)

3.1.2 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2020-2022)

3.2 Global Pneumococcal Vaccine Polyvalent Annual Revenue by Company (2020-2022)

3.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Company (2020-2022)

3.2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Company (2020-2022)

3.3 Global Pneumococcal Vaccine Polyvalent Sale Price by Company

3.4 Key Manufacturers Pneumococcal Vaccine Polyvalent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pneumococcal Vaccine Polyvalent Product Location Distribution

3.4.2 Players Pneumococcal Vaccine Polyvalent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pneumococcal Vaccine Polyvalent by Geographic Region

4.1 World Historic Pneumococcal Vaccine Polyvalent Market Size by Geographic Region (2017-2022)

4.1.1 Global Pneumococcal Vaccine Polyvalent Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pneumococcal Vaccine Polyvalent Annual Revenue by Geographic Region

4.2 World Historic Pneumococcal Vaccine Polyvalent Market Size by Country/Region (2017-2022)

4.2.1 Global Pneumococcal Vaccine Polyvalent Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pneumococcal Vaccine Polyvalent Annual Revenue by Country/Region

4.3 Americas Pneumococcal Vaccine Polyvalent Sales Growth

4.4 APAC Pneumococcal Vaccine Polyvalent Sales Growth

4.5 Europe Pneumococcal Vaccine Polyvalent Sales Growth

4.6 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Growth

5 Americas

5.1 Americas Pneumococcal Vaccine Polyvalent Sales by Country

5.1.1 Americas Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022)

5.1.2 Americas Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022)

5.2 Americas Pneumococcal Vaccine Polyvalent Sales by Type

5.3 Americas Pneumococcal Vaccine Polyvalent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pneumococcal Vaccine Polyvalent Sales by Region

6.1.1 APAC Pneumococcal Vaccine Polyvalent Sales by Region (2017-2022)

6.1.2 APAC Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2022)

6.2 APAC Pneumococcal Vaccine Polyvalent Sales by Type

6.3 APAC Pneumococcal Vaccine Polyvalent Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pneumococcal Vaccine Polyvalent by Country

7.1.1 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022)

7.1.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022)

7.2 Europe Pneumococcal Vaccine Polyvalent Sales by Type

7.3 Europe Pneumococcal Vaccine Polyvalent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pneumococcal Vaccine Polyvalent by Country

8.1.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022)

8.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type

8.3 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccine Polyvalent

10.3 Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent

10.4 Industry Chain Structure of Pneumococcal Vaccine Polyvalent

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pneumococcal Vaccine Polyvalent Distributors

11.3 Pneumococcal Vaccine Polyvalent Customer

12 World Forecast Review for Pneumococcal Vaccine Polyvalent by Geographic Region

12.1 Global Pneumococcal Vaccine Polyvalent Market Size Forecast by Region

12.1.1 Global Pneumococcal Vaccine Polyvalent Forecast by Region (2023-2028)

12.1.2 Global Pneumococcal Vaccine Polyvalent Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pneumococcal Vaccine Polyvalent Forecast by Type

12.7 Global Pneumococcal Vaccine Polyvalent Forecast by Application

13 Key Players Analysis

13.1 Merck & Co.

13.1.1 Merck & Co. Company Information

13.1.2 Merck & Co. Pneumococcal Vaccine Polyvalent Product Offered

13.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co. Main Business Overview

13.1.5 Merck & Co. Latest Developments

14 Research Findings and Conclusion

Table 1. Pneumococcal Vaccine Polyvalent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pneumococcal Vaccine Polyvalent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Prevnar 13

Table 4. Major Players of Pneumovax23

Table 5. Global Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)

Table 6. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

Table 7. Global Pneumococcal Vaccine Polyvalent Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2017-2022)

Table 9. Global Pneumococcal Vaccine Polyvalent Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)

Table 11. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Table 12. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2017-2022)

Table 13. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2017-2022)

Table 14. Global Pneumococcal Vaccine Polyvalent Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Pneumococcal Vaccine Polyvalent Sales by Company (2020-2022) & (K Units)

Table 16. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2020-2022)

Table 17. Global Pneumococcal Vaccine Polyvalent Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Company (2020-2022)

Table 19. Global Pneumococcal Vaccine Polyvalent Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Pneumococcal Vaccine Polyvalent Producing Area Distribution and Sales Area

Table 21. Players Pneumococcal Vaccine Polyvalent Products Offered

Table 22. Pneumococcal Vaccine Polyvalent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pneumococcal Vaccine Polyvalent Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Pneumococcal Vaccine Polyvalent Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pneumococcal Vaccine Polyvalent Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pneumococcal Vaccine Polyvalent Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pneumococcal Vaccine Polyvalent Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)

Table 34. Americas Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2022)

Table 35. Americas Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2022)

Table 37. Americas Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)

Table 38. Americas Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

Table 39. Americas Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)

Table 40. Americas Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Table 41. APAC Pneumococcal Vaccine Polyvalent Sales by Region (2017-2022) & (K Units)

Table 42. APAC Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2022)

Table 43. APAC Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2017-2022)

Table 45. APAC Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)

Table 46. APAC Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

Table 47. APAC Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)

Table 48. APAC Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Table 49. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)

Table 50. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2022)

Table 51. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2022)

Table 53. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)

Table 54. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

Table 55. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)

Table 56. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccine Polyvalent

Table 66. Key Market Challenges & Risks of Pneumococcal Vaccine Polyvalent

Table 67. Key Industry Trends of Pneumococcal Vaccine Polyvalent

Table 68. Pneumococcal Vaccine Polyvalent Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pneumococcal Vaccine Polyvalent Distributors List

Table 71. Pneumococcal Vaccine Polyvalent Customer List

Table 72. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Pneumococcal Vaccine Polyvalent Sales Market Forecast by Region

Table 74. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Pneumococcal Vaccine Polyvalent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pneumococcal Vaccine Polyvalent Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Pneumococcal Vaccine Polyvalent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Pneumococcal Vaccine Polyvalent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pneumococcal Vaccine Polyvalent Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pneumococcal Vaccine Polyvalent Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck & Co. Basic Information, Pneumococcal Vaccine Polyvalent Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck & Co. Pneumococcal Vaccine Polyvalent Product Offered

Table 94. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Merck & Co. Main Business

Table 96. Merck & Co. Latest Developments

Table 97. Pfizer Basic Information, Pneumococcal Vaccine Polyvalent Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Pneumococcal Vaccine Polyvalent Product Offered

Table 99. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Pneumococcal Vaccine Polyvalent

Figure 2. Pneumococcal Vaccine Polyvalent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pneumococcal Vaccine Polyvalent Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pneumococcal Vaccine Polyvalent Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pneumococcal Vaccine Polyvalent Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Prevnar 13

Figure 10. Product Picture of Pneumovax23

Figure 11. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2021

Figure 12. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2017-2022)

Figure 13. Pneumococcal Vaccine Polyvalent Consumed in 18 Years and Younger

Figure 14. Global Pneumococcal Vaccine Polyvalent Market: 18 Years and Younger (2017-2022) & (K Units)

Figure 15. Pneumococcal Vaccine Polyvalent Consumed in 19 To 64 Years Old

Figure 16. Global Pneumococcal Vaccine Polyvalent Market: 19 To 64 Years Old (2017-2022) & (K Units)

Figure 17. Pneumococcal Vaccine Polyvalent Consumed in 65 Years and Older

Figure 18. Global Pneumococcal Vaccine Polyvalent Market: 65 Years and Older (2017-2022) & (K Units)

Figure 19. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2022)

Figure 20. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application in 2021

Figure 21. Pneumococcal Vaccine Polyvalent Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Company in 2021

Figure 23. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Geographic Region in 2021

Figure 25. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2022)

Figure 26. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Country/Region in 2021

Figure 27. Americas Pneumococcal Vaccine Polyvalent Sales 2017-2022 (K Units)

Figure 28. Americas Pneumococcal Vaccine Polyvalent Revenue 2017-2022 ($ Millions)

Figure 29. APAC Pneumococcal Vaccine Polyvalent Sales 2017-2022 (K Units)

Figure 30. APAC Pneumococcal Vaccine Polyvalent Revenue 2017-2022 ($ Millions)

Figure 31. Europe Pneumococcal Vaccine Polyvalent Sales 2017-2022 (K Units)

Figure 32. Europe Pneumococcal Vaccine Polyvalent Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue 2017-2022 ($ Millions)

Figure 35. Americas Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2021

Figure 36. Americas Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2021

Figure 37. United States Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Pneumococcal Vaccine Polyvalent Sales Market Share by Region in 2021

Figure 42. APAC Pneumococcal Vaccine Polyvalent Revenue Market Share by Regions in 2021

Figure 43. China Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2021

Figure 50. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2021

Figure 51. Germany Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2021

Figure 58. Egypt Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Pneumococcal Vaccine Polyvalent Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine Polyvalent in 2021

Figure 64. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent

Figure 65. Industry Chain Structure of Pneumococcal Vaccine Polyvalent

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles